Case A 32 year old woman comes with complaint of numbness and tingling sensation in her right hand. Her symptoms began several days ago and have progressively.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

A&P Signs & Symptoms Management of condition
DEMYELINATING DISEASES (MULTIPLE SCLEROSIS)
Dayna Ryan, PT, DPT Winter  Primarily known as a disease of CNS myelin (demyelination)  Recent evidence shows early involvement of CNS axons as.
Demyelinating Diseases. Demyelination is a common degenerative change in the nervous system secondary to neuronal or axonal injury, But in the group of.
Pain in Multiple Sclerosis Pain in Multiple Sclerosis Dr:Moallemy.
Overview of Multiple Sclerosis  Valerie Robinson, D.O. 
IgG IEF Diagnosing Multiple Sclerosis. Multiple Sclerosis CNS disorder Scar formation on outside of nerve cells of brain and spinal cord Inflammation.
What is MS? Multiple Sclerosis (MS) is an inflammatory disease of the Central Nervous System (CNS) - that's the brain and spinal cord. Predominantly,
MULTIPLE SCLEROSIS Dr. Belal M. Hijji, RN. PhD February 27, 2012.
MULTIPLE SCLEROSIS Dr Mehran Homam Department of neurology.
Management of patient with neurological disorders
MULTIPLE SCLEROSIS CLAIRE BISCHOFF, ASHLEY FOLDEN, AND CASSIE NEWMAN.
Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 23 Drugs for Multiple Sclerosis.
MULTIPLE SCLEROSIS In multiple sclerosis, one of the most common neurological causes of long-term disability, the myelin-producing oligodendrocytes of.
Multiple sclerosis Pathology. Key principles Myelin function The differences between CNS and PNS Myelin Primary Demyelinating disease classification Multiple.
Multiple Sclerosis (MS) By: Morgan Farr Biology 1010.
Multiple Sclerosis Jessica Kelly-Hannon It’s causes, effects and treatments.
Multiple Sclerosis (Definition)  “Multiple Sclerosis is a progressive demyelination of neurons in the central nervous system (the Brain and the Spinal.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Multiple Sclerosis. Inflammatory demyelinating disease of the central nervous system. Most common cause of neurological disability in young adults.
Friends With MS.com Bringing you support and information for Multiple Sclerosis.
Pediatric Neurology Use of Biologic and Chemotherapeutic Agents Pediatric Neurology Use of Biologic and Chemotherapeutic Agents.
Neuromuscular Disorders Brenda P. Johnson, PhD, RN.
By: Nathan & James. Our Patient (Totally breaking HIPPA) Name: Helen Weezy F Baby Age: 28 Symptoms: Strange pricks in her hands and feet, fatigue, impaired.
Adam Percey. What is it?  MS is a disease of the central nervous system.  What happens is the myelin sheaths around the axon of a nerve fade away. These.
Multiple Sclerosis Rohith M. Reddy. Multiple sclerosis (MS) involves an immune-mediated process in which an abnormal response of the body’s immune system.
Guillain-Barré Syndrome Miss Fatima Hirzallah Guillain-Barré syndrome is an autoimmune attack on the peripheral nerve myelin. The result is acute, rapid.
Multiple Sclerosis Brett Catlin Period Seven September 3 rd, 2003.
Acute inflammatory demyelinating polyradiculoneuropathy (AIDP)
Update on Multiple Sclerosis Helen Ford Consultant Neurologist Leeds Teaching Hospitals NHS Trust.
Multiple Sclerosis Alan Chen 4/1/14. General Information Other names: disseminated sclerosis or encephalomyelitis disseminata Inflammatory disease that.
Boston Medical Center is the primary teaching affiliate of the Boston University School of Medicine. PRESENTATION TITLE Subtitle & Date.
Sagittal FLAIR images - Stable nonenhancing hyperintensities within the pericallosal white matter and bilateral centrum semiovale, consistent with known.
Multiple Sclerosis A chronic, progressive central nervous system disease with a disseminating demyelination of the nerve fibers of the brain and spinal.
Multiple Sclerosis Jesse Mohoric and Sarah Davis.
Adult Medical-Surgical Nursing Neurology Module: Multiple Sclerosis.
GROUP MEMBERS  Vanessa Wickham  Satrupa Devi Singh  Joshua Griffith  Jennifer Hayner  Carlwyn Collins  Ashley Singh.
Vasculitis Vasculitis arises when immune system mistakenly attacks blood vessels. What causes this attack isn't fully known, but it can result from infection.
Demyelinating Disease August 27, Pathologic Criteria Destruction of myelin Sparing of other elements of the nervous tissue Infiltration of inflammatory.
Int J MS Care 7: , 2005/2006. Jan 9 & 10, Clinical Stabilization of a MS Patient after Tonsillectomy presented by Michael C. Levin, MD Department.
Updates on Optic Neuritis Briar Sexton Neuro-ophthalmology Clinical Day Friday, November 18, 2005.
MULTIPLE SCLEROSIS Ana Costas Barreiro.
MS مولتیپل اسکلروزیس. Client with Multiple Sclerosis Description Chronic demyelinating disease of CNS associated with - abnormal immune response to environmental.
Department of Neurology, The 2nd affiliated hospital, kunming Medical College Yinfengqiong.
Nervous System Diseases & Disorders Notes. Head Trauma #1 cause of trauma deaths in US Many possible mechanisms of injury: Falls Motor vehicle crashes.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
EXEMPLAR OF MULTIPLE SCLEROSIS INTRODUCTION AND ASSESSMENT.
Pathology and Pathogenesis of Multiple Sclerosis
Neurological Disorders
MULTIPLE SCLEROSIS BY EMILY HOWARD. Multiple Sclerosis (MS) Multiple sclerosis (or MS) is a chronic, often disabling disease of the immune system that.
1 Adult Health II Neurological Diseases Jerry Carley RN, MSN, MA, CNE Summer 2010.
Short Case Presentation Dr. Sania Khalid. Background Young female developed quadriplegia over a year Bed-ridden for 2 months Loss of bowel and bladder.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
Multiple Sclerosis. Multiple sclerosis (MS) is a disease that affects central nervous system (brain and spinal cord). It damages the myelin sheath. 
Nursing management of Multiple sclerosis
Multiple sclerosis – late onset. Authors: Vitalie Vacaras Vitalie Vacaras Damian Popescu Damian Popescu Radu Antonescu Radu Antonescu Anca Simu Anca Simu.
Guillain-Barre Syndrome
Nervous System Disorders and Homeostatic Imbalances
OPTIC NEURITIS DR ADNAN.
Multiple sclerosis.
By: Julie Carrasco, Brianna Macias, Alexx Rusake
Multiple sclerosis Pathology.
Multiple Sclerosis.
DR. SADIK AL-GHAZAWI CONSULTANT NEUROLOGIST MRCP, FRCP UK.
Neuro-ophthalmology.
Multiple Sclerosis.
GUILLAIN BARRE SYNDROME DIANA COHEN. WHAT IS GUILLAIN BARRE SYNDROME AUTOIMMUNE DISORDER UNKNOWN CAUSE.
Disease of the Central Nervous System By Eric Nauman
Presentation transcript:

Case A 32 year old woman comes with complaint of numbness and tingling sensation in her right hand. Her symptoms began several days ago and have progressively worsened over the last several hours. When asked, she states that 3 years ago she had an episode of “seeing double” that lasted for 2 days and resolved on its own. Physical examination is significant for hyperreactive reflexes bilaterally in her lower extremities. Increased spasticity is also noted in her lower extremities. What is the Most Likely diagnosis? 10/13/2015Dr. Alka Stoelinga1

MULTIPLE SCLEROSIS 10/13/20152Dr. Alka Stoelinga

MULTIPLE SCLEROSIS Multiple sclerosis is an inflammatory disease of CNS white matter characterized by relapsing or progressive course Multiple sclerosis is a common disease of unknown cause in which there are multiple areas of Demyelination within brain and the spinal cord.  Peak incidence: years Male: Female = 1:2 10/13/20153Dr. Alka Stoelinga

Etiology: Multifactorial causation : – Genetic, environmental (Infectious, dietary, climatic), immunologic MS lesions most commonly involve white matter areas close to the ventricles of the cerebellum, brain stem, basal ganglia, spinal cord; and the optic nerve. Immune mechanism against CNS myelin sheath is suggested due to presence of increased levels of activated T-Lymphocytes in the CSF, and increased immunoglobulin synthesis within the CNS 10/13/2015Dr. Alka Stoelinga4

Pathology – Activation of lymphocytes in response to myelin proteins (auto antigen). – Destruction of the myelin. – Initiation of inflammation and infiltration of the macrophage and lymphocytes – Later on healing by gliosis, loss of neuronal function – Initially inflammation leads to transient loss of function but later permanent deficit occur due to disruption of axonal integrity – Demyelination may impair nerve conduction that lowers the efficiency of CNS function – It also causes ectopic impulse generation that causes Paresthesia. 10/13/20155Dr. Alka Stoelinga

Nerve 10/13/20156Dr. Alka Stoelinga

10/13/20157Dr. Alka Stoelinga

Clinical features Presentation- – Weakness, numbness, tingling or unsteadiness of a limb. – Urinary urgency or retention – Blurry vision – Double vision 1.Relapsing and remitting MS:80% of patients have a relapsing and remitting course of neurological deficit 1.Characterized by recurrent attacks of neurologic dysfunction. The attacks generally evolve over days to weeks and may be followed by complete, partial or no recovery. Recovery occurs usually spontaneously within weeks to several months 2. 20% follow a slowly progressive :  Secondary progressive MS  The disease has relapsing-remitting course at first but evolves to be progressive and this phase may begin shortly after disease onset or delayed for several months or years.  Primary progressive MS  Characterized by gradual progression of disability from the onset of disease 3. And minority have fatal disease causing early death Peak age of onset is in the fourth decade Frequent relapse and incomplete recovery indicate poor prognosis. Physical signs observed in multiple sclerosis depend on the anatomical site of Demyelination 10/13/20158Dr. Alka Stoelinga

Scenario Young patient (Usually <55years) H/O multiple neurological complaints that cannot be explained by presence of one CNS lesion 10/13/2015Dr. Alka Stoelinga9

Initial presenting features of Multiple sclerosis: Blurring of vision due to optic neuritis Diplopia Weakness in one or more limbs Paresthesia Ataxia Urinary symptoms 10/13/201510Dr. Alka Stoelinga

End stage multiple sclerosis: Patient is severely disabled with spastic paraparesis, ataxia, optic atrophy, nystagmus, pseudobulbar palsy, incontinence of urine, dementia Death occurs usually due to bronchopneumonia and renal failure. 10/13/201511Dr. Alka Stoelinga

10/13/201512Dr. Alka Stoelinga

10/13/201513Dr. Alka Stoelinga

10/13/201514Dr. Alka Stoelinga

10/13/201515Dr. Alka Stoelinga

MRIMRI scans (post-contrast) of the same brain slice at monthly intervals. Bright spots indicate active lesions. 10/13/201516Dr. Alka Stoelinga

Investigations Clinical picture Identify multiple sites of neurological involvement i.e., plaques of Demyelination by imaging: MRI and Myelography Provide evidence for an inflammatory disorder: CSF examination(cell count and protein electrophoresis) Demonstrate other sites of involvement by: Visual and other evoked potentials Exclude other conditions: CXR, Serum ACE and serum B12 antibodies 10/13/201517Dr. Alka Stoelinga

Differential diagnosis: 1.SLE 2.Stroke 3.Friedreich’s ataxia 4.CNS sarcoidosis 5.Bechcet’s syndrome 6.Sjogren’s syndrome 10/13/201518Dr. Alka Stoelinga

Treatment Acute relapse – High-dose intravenous steroids (Methylprednisolone 1 g daily for 3 days followed by tapering dosage of oral Prednisolone for next 4 weeks) Preventing relapses – Immunosuppressive agents including Azathioprine have a marginal effect in reducing relapses and improving long-term outcome – Interferon Beta-1A – Interferon Beta 1B reduces the number of relapses – Glatiramer acetate(Immune modulator) 10/13/201519Dr. Alka Stoelinga

Treatment of complications  Spasticity: Regular Physiotherapy Baclofen (most effective)  Painful Paresthesia: Carbamazepine Amitriptyline  Ataxia: Isoniazid and clonazepam  Care of bowel and bladder 10/13/201520Dr. Alka Stoelinga

Treatment MS and fatigue  Amantidine MS with Urinary incontinence  Oxybutanine MS and urinary retention  Bethanicol 10/13/2015Dr. Alka Stoelinga21

Prognosis About 15% of those having one attack of Demyelination do not suffer any more events Approximately 5% of patients die within 5 years of onset After 10 years, about one-third of patients are disabled to the point of needing help with walking 10/13/201522Dr. Alka Stoelinga

Cavernous sinus thrombosis Cavernous sinus thrombosis (CST) is the formation of a blood clot within the cavernous sinus, a cavity at the base of the brain which drains deoxygenated blood from the brain back to the heart. The cause is usually from a spreading infection in the sinuses, ears, or teeth. Staphylococcus aureus and Streptococcus are often the associated bacteria. Cavernous sinus thrombosis causes decrease or loss of vision drooping or bulging eyes Headaches paralysis of the cranial nerves which courses/runs through the cavernous sinus. This infection is life-threatening and requires immediate treatment, which usually includes antibiotics and sometimes surgical drainage. 10/13/201523Dr. Alka Stoelinga

Cavernous sinus thrombosis 10/13/201524Dr. Alka Stoelinga

WERNICKE-KORSAKOFF DISEASE Due to a deficiency of thiamine Causes are: 1. Malnutrition 2.Alcoholism 3. Malabsorption 4.Protracted vomiting. There is failure of carbohydrate metabolism (because thiamin is a co- factor in many enzymes of the citric acid cycle) and accumulation of glutamate. Clinical triad is that of Ophthalmoplegia, ataxia, and global confusion Patients are profoundly disoriented, If the disease is not treated  stupor, coma, and death may ensue. 10/13/201525Dr. Alka Stoelinga

Approximately half recover incompletely, ataxia is very slow to recover or may not recover. Later on Korsakoff’s psychosis may occur (characterized by loss of recent memory, confabulation, impaired temporal sequencing of events) Treatment – Administer to all chronic alcoholic patients especially before giving intravenous glucose for suspected hypoglycemia. – Intravenous or intramuscular thiamin 50 mg TDS – Later on switched over oral therapy 100 mg TDS 10/13/201526Dr. Alka Stoelinga

Qs 1.Difference between UMNL and LMNL 2.Causes of spinal cord injury and its C/F 3.Clinical features and causes of spinal cord compression 4.Management of Spinal cord compression 5.Short notes on 1.Cervical Spondylosis 2.Brown sequard syndrome 3.Syringomyelia 10/13/2015Dr. Alka Stoelinga27